Note: Descriptions are shown in the official language in which they were submitted.
CA 02315799 2000-06-16
WO 99/33440 PC'f/EP98/08148
NON-WHITENINC3 UNDERARM COMPOSITIONS
BACRC~ROUND OF THE INVENTION
Field of the Iaveation
The invention relates to non-whitening underarm
compositions having perspiration inhibiting properties
and/or deodorancy.
The Related Art
Antiperspirant products frequently result in objectionable
aesthetic characteristics including tackiness and
whitening. The term whitening refers to the presence of
visible residues of white substances remaining on the
skin.
U.S. Patent 5,449,511(Coe) reports an anhydrous
antiperspirant product containing a non-volatile water
soluble liquid masking agent interactive with the
antiperspirant active salt. The interaction is reported
to essentially eliminate discernible whitening without
substantially diminishing perspiration inhibiting
activity. Most preferred as masking agent are alkoxylated
alcohols such as PPG-10 butane diol and dimethicone
copolyol.
A problem often encountered with masking agents is that
they interfere with other physical properties. For
instance, solid, gel or cream type products require
structurants to impart rigidity. Many masking agents
plasticize to increase tackiness and interfere with the
structurant effect. Consequently, considerable research
has been conducted to discover non-whitening agents which
have little or no adverse affect on other physical
properties.
CA 02315799 2000-06-16
WO 99/33440 PCT/EP98/08148
2
Accordingly, it is an object of the present invention to
provide an underarm product which after application
leaves, for at least 1 hour, preferably 3 hours but
optimally 24 hours, transparent (non-white) product
residues on the skin.
Another object of the present invention is to provide an
underarm product which not only is non-whitening but also
has no detrimental effect upon other physical properties
of the product.
These and other objects of the present invention will
become more readily apparent from consideration of the
following summary and detailed description.
SU1~ARY OF THE INVENTION
A non-whitening underarm composition is provided
including:
(i) an underarm active present in an effective amount
to inhibit odor or to reduce perspiration;
(ii) from 5 to 80~ by weight of the composition of
hexameric cyclomethicone; and
(iii) from 0 to 35~ by weight based on total
cyclomethicone present in the composition of
tetrameric and pentameric cyclomethicone.
DETAILED DESCRIPTION OF THE INVENTION
Now it has been found that non-whitening underarm
compositions can be achieved through incorporation of a
volatile siloxane of predominantly hexameric
CA 02315799 2000-06-16
WO 99/33440 PCT/EP98/08148
3
cyclomethicone. These compositions require restriction on
the amounts of tetramer and pentamer. Thus, no more than
35~, preferably no more than 20~, and optimally no more
than 10~ of these lower molecular weight cyclomethicones,
based on total weight cyclomethicone, should be present in
the compositions. In terms of weight ratio, the amount
of hexameric to combined tetrameric/pentameric
cyclomethicone will be at least about 1:1, preferably at
least about 2:1.
A first essential element of compositions according to the
invention is that of a deodorant and/or antiperspirant
active. Most preferable is an astringent salt which
combines the properties of deodorancy and antiperspirancy.
Suitable astringents may be inorganic or organic salts of
aluminum, zirconium, zinc and mixtures thereof. Salts
useful as astringents or as components of astringent
complexes include aluminum halides, aluminum
hydroxyhalides, zirconyl oxyhalides, zirconyl
hydroxyhalides and mixtures of these salt materials.
Aluminum salts of this type include aluminum chloride and
the aluminum hydroxyhalides having the general formula A1z
(OH)xQY-XH20 where Q is chlorine, bromine or iodine, where x
is 2 to 5 and x+y=6 and x and y do not need to be
integers; and where X is about 1 to 6.
Zirconium compounds which are useful may be represented by
the following general empirical formula: Zn0(OH)z_~sB=
wherein z may vary from about 0.9 to 2 and need not be an
integer, n is the valence of B, 2-nz is greater than or
equal to 0, and B may be selected from the group
consisting of halides, nitrate, sulfamate, sulfate and
mixtures thereof. As with the basic aluminum compounds,
it will be understood that the aforementioned formula is
greatly simplified and is intended to represent and
include compounds having coordinated and/or bound water in
CA 02315799 2000-06-16
WO 99133440 PCT/EP98/08148
4
various quantities, as well as polymers, mixtures and
complexes of the above. Zirconium hydroxy salts actually
represent a range of compounds having various amounts of
the hydroxy group, varying from about 1.1 to only slightly
greater than 0 groups per molecule.
Several types of complexes utilizing the above astringent
salts are known in the art. For example, U.S. Patent
3,792,068 (Luedders et al.), discloses complexes of
aluminum, zirconium and amino acids such as glycine.
Complexes reported therein and similar structures are
commonly known as ZAG. The ZAG complexes ordinarily have
an Al:Zr ratio of from about 1.67 to 12.5 and a Metal: C1
ratio of from about 0.73 to 1.93. A preferred aluminum
compound for preparation of ZAG type complexes is aluminum
chlorhydroxide of the empirical formula A12(OH)5C1'2Hz0.
Preferred zirconium compounds for preparation of ZAG-type
complexes are zirconyl hydroxychloride having the
empirical formula Zr0(OH)C1'3Hz0 and the zirconyl
hydroxyhalides of the empirical formula
Zr0 (OH) z_aCla'nH20 wherein a is from 1. 5 to 1. 87 and n is
from about 1 to 7. The preferred amino acid for preparing
such ZAG-type complexes is glycine of the formula
CHz(NH2)COOH. Spherical ZAG, with particle size 1 to 100
microns, is especially preferred.
More specifically, the following is a list antiperspirant
actives useful for the present invention which have
approved in listings under the United States Food & Drug
Administration, Federal Register. They include aluminum
chloride, aluminum chlorohydrate, aluminum chlorohydrex,
aluminum chlorohydrex PEG, aluminum chlorohydrex PG,
aluminum dichlorohydrate, aluminum dichlorohydrex PEG,
aluminum dichlorohydrex PG, aluminum sesquichlorohydrate,
aluminum sesquichlorohydrex PEG, aluminum
sesquichlorohydrex PG, aluminum sulfate, aluminum
zirconium octachlorohydrate, aluminum zirconium
CA 02315799 2000-06-16
WO 99/33440 PGT/EP98/08148
octachlorohydrex GLY, aluminum zirconium
pentachlorohydrate, aluminum zirconium pentachlorohydrex
GLY, aluminum zirconium tetrachlorohydrate, aluminum
zirconium trichlorohydrate, aluminum zirconium
5 tetrachlorohydrate GLY and aluminum zirconium
trichlorohydrate GLY.
Amounts of the deodorant/antiperspirant active may range
from 0.1 to 70~. When the active is an astringent salt,
the amounts may range from 1~ to 70~, preferably from 15~
to 60~ by weight calculated on an anhydrous metal salt
basis (exclusive of glycine, the salts of glycine or other
complexing agents).
Deodorant actives according to the present invention also
include materials other than those functioning as
antiperspirants. Deodorants should be capable of killing
or hindering the growth of microorganisms that generate
malodor or that promote the decomposition of body oils
into odiferous fatty acids. Most prominent among organic
antimicrobial materials are triclosan, triclorban,
chlorhexedine and certain fragrant oils known as deo
perfumes (e. g. U.S. Patent 4,278,658 to Hooper et al.).
Amounts of the organic antimicrobial materials may range
from 0.01 to 1~, preferably 0.1 to 0.5~ by weight.
Inorganic antimicrobial materials may also serve as
deodorant actives. These include zinc oxide, zinc
hydroxide, zinc carbonate, zinc phenolsulfonate, magnesium
oxide, magnesium hydroxide, magnesium carbonate, lanthanum
oxide, lanthanum hydroxide, lanthanum carbonate, sodium
bicarbonate, potassium bicarbonate and combinations
thereof. Amounts of the inorganic materials may range from
0.1 to 60~ by weight.
A second essential element to be incorporated into the
compositions of this invention is that of a volatile
siloxane which is a cyclomethicone hexamer. This material
CA 02315799 2000-06-16
WO 99/33440 PCT/EP98/08148
6
may be present in amounts from 5 to 80~, preferably from
15 to 60~, optimally from 30 to 50~ by weight. The
hexamer will have the structure:
Si(CH3)2
Sl(CH3)2- ~ Sl(~3)2-
(~3)2S1 ~-(CH3)2S1
Si(CH3)2
Compositions of the present invention preferably will not
contain any low molecular weight cyclomethicones. For
instance, levels of tetrameric and pentameric
cyclomethicone together will be no higher than 35~,
preferably no higher than 20~ by weight of the total
cyclomethicone present in the compositions. Hexameric
cyclomethicone is commercially available as DC 246 from
the Dow Corning Company.
Compositions of the present invention may also contain a
powdered filler. Illustrative of this category are
starches, talc, fumed silica (e.g. Cab-O-Sil from the
Cabot Corporation), finely divided silica (e. g. sodium
silicate), magnesium aluminum silicate, clays and mixtures
thereof. Most preferred and effective are corn starch and
modified starches, especially aluminum starch octenyl
succinate, commercially available from the National Starch
& Chemical Company under the trademark Dry Flo7.
Amounts of the powdered filler can range from 1 to 40~,
preferably from 10 to 35~, optimally from 15 to 30~ by
weight.
Organopolysiloxane elastomers may optionally be present.
They will have an average number molecular weight in
excess of 2,000, preferably in excess of 1,000,000 and
CA 02315799 2000-06-16
WO 99/33440 PCT/EP98/08148
7
optimally will range from 10,000 to 20 million.
Particularly preferred are crosslinked non-emulsifying
siloxane elastomers. The term "non-emulsifying" defines a
siloxane from which polyoxyalkylene units are absent.
Advantageously the elastomers are formed from a divinyl
monomer reacting with Si-H linkages of a siloxane
backbone. Elastomer compositions are commercially
available from the General Electric Company under product
designation General Electric Silicone 1229 with proposed
CTFA name of Cyclomethicone and Vinyl
Dimethicone/Methicone Cross Polymer, delivered as 20-35~
elastomer in a cyclomethicone carrier. A related
elastomer composition under the CTFA name of Crosslinked
Stearyl Methyl Dimethyl Siloxane Copolymer is available as
Gransil SR-CYC (25-35~ elastomer in cyclomethicone) from
Grant Industries, Inc., Elmwood Park, New Jersey. The
commercial products from General Electric and Grant
Industries ordinarily are further processed by subjecting
them to a high pressure (approximately 1,500 to 3,500 psi)
treatment in a Sonolator with recycling in 10 to 60
passes. Sonolation achieves a resultant fluid with
elastomer average particle size ranging from 0.2 to 10
micron, preferably 0.5 to 5 micron. Viscosity is best
when ranging between 300 and 20,000 cps at 25°C as measured
by a Brookfield LV Viscometer (size 4 bar, 60 rpm, 15
sec . ) .
Amounts of the elastomer may range from 0.05 to 30~,
optimally from 0.5 to 15~, most preferably from 2 to 10~
by weight.
Optionally there may also be present Clz-C,o hydrocarbon.
Amounts of this material may range from 1 to 40~,
preferably from 5 to 25~, optimally from 10 to 20~ by
weight. The C1z-C,o hydrocarbon when present may have a
viscosity from 10 to 5,000 centistokes at 25°C. The
hydrocarbon is preferably a CZO-C,o substance that may
CA 02315799 2000-06-16
WO 99/33440 PCT/EP98/08148
8
either be saturated or unsaturated. Examples include
dodecane, tridecane, tetradecane, pentadecane, hexadecane,
heptadecane, octadecane, nonadecane, ecosane, heneicosane,
docosane, tricosane, tetracosane, pentacosane, isomers of
these compounds and mixtures thereof. Most preferred is
polydecene available from the Ethyl Corporation under the
Ethylflo trademark.
Inert organic particulates may also be included in
compositions of the present invention. Illustrative of
such materials are the polyolefins (such as polyethylene
and polypropylene) and nylon. Most preferred are the
spherical or non-spherical polyethylene powders. Amounts
of these materials may range from 0.1 to 20~, preferably
from 1 to 10~ by weight.
Waxes may also be incorporated in compositions of the
present invention. Animal origin waxes include beeswax,
spermaceti, lanolin and shellac wax. Vegetable origin
waxes include carnauba, candelilla, bayberry and sugarcane
wax. Especially useful is hydrogenated castor wax.
Amounts of the wax may range from 0.5 to 30~ by weight.
Compositions of this invention may be in stick, gel, cream
and aerosol form. Most preferred however is the cream
form, especially ultra dry creams. These creams will have
a cone penetration value ranging from 2 to 36 mm,
preferably from 10 to 25 mm, optimally from 12 to 20 mm as
measured in the Standard Test Method for Cone Preparation
of Petrolatum (ASTM D 937).
Advantageously, compositions of the present invention may
be anhydrous. By the term "anhydrous" is meant an amount
of free water ranging from 0 to 5~, preferably no higher
than 3~ by weight. Water complexed with aluminum salts
may also be present but is not included within the term
anhydrous.
CA 02315799 2000-06-16
WO 99/33440 PCT/EP98/08148
9
The following examples will more fully illustrate the
embodiments of this invention. All parts, percentages and
proportions referred to herein and in the appended claims
are by weight of the total composition unless otherwise
indicated.
»pLlrs i-~
Formulations in the following Table are dry cream
compositions falling within the present invention.
CA 02315799 2000-06-16
WO 99/33440 PCT/EP98/08148
TABLE I
COMPONENT EXAMPLE
(NEIQHT
%)
1 2 3 4 5 6 7
Hexameric 29.7 29.7 29.7 29.7 68.0 50.0 50.0
Cyclomethicone
Crosslinked 13.5 13.5 13.5 13.5 6.0 2.0 1.0
Elastomer (25~
in Hexameric
Cyclomethicone)
Polydecene 3Ei4 10.8 10.8 10.8 10.8 -- 10.8 10.8
ZAG 26.0 26.0 26.0 -- 26.0 26.0 26.0
Triclosan -- -- -- 0.5 -- -- --
Corn Starch 20.0 -- 18.5 20.0 -- 11.2 --
Talc -- 20.0 -- 20.0 -- -- 11.2
Fumed Silica -- -- 1.5 5.5 -- -- 1.0
5 EXAMPLE 8
An aerosol antiperspirant composition according to the
present invention is outlined under Table II.
15
CA 02315799 2000-06-16
WO 99/33440 PCT/EP98/08148
11
TABLE II
COMPONENT WEIGHT %
Hexameric Cyclomethicone (DC 246) 43.2
ZAG 6.7
GE 1229 (25~ elastomer in 6.6
cyclomethicone)
Bentone 38CG~ 3.5
Isobutane (propellant) 40.0
EXAMPLE 9
Another aerosol antiperspirant composition according to
the present invention is outlined under Table III.
TABLE III
COMPONENT WEIGgT %
Aluminum Chlorhydrate 12.0
Isopropyl myristate 7.1
Hexameric Cyclomethicone (DC 246) 7.0
GE 1229 (25~ elastomer in 3.0
cyclomethicone)
Bentone 38~ 1.3
Propylene Carbonate 0.4
Isobutane/Propane ~ 69.2
EXAMPLE 10
A solid stick antiperspirant composition according to the
present invention is outlined under Table IV.
CA 02315799 2000-06-16
WO 99/33440 PCT/EP98/08148
12
TABLE IV
COMPONENT WEIGHT %
Hexameric Cyclomethicone (DC 43.9
246 )
Activated Aluminum Chlorhydrate 22.6
Talc 20.0
Stearyl Alcohol 11.5
Fragrance 1.0
GE 1229 (25~ elastomer in DC 1.0
246)
EXAMPLE 11
A gel formulation according to the present invention is
outlined under Table V.
TABLE V
COMPONENT WEIGHT %
ZAG 24.2
Dipropylene Glycol 18.0
Dimethicone Copolyol (25~ in DC 14.3
246)
Hexameric Cyclomethicone (DC 13.9
246)
GE 1229 (25$ in DC 246) 5.0
Polysorbate 20 1.0
Water qs
EXAMPLE 12
This Example presents comparative performance results with
the selected cyclomethicones in an antiperspirant stick
formulation. Six stick antiperspirants were formulated
CA 02315799 2000-06-16
WO 99/33440 PCT/EP98/08148
13
with various ratios of pentameric and hexameric
cyclomethicones. The basic compositions are outlined in
Table VI below.
TABLE VI
COMPONENT WEIC3HT %
Cyclomethicone 53.0
Stearyl Alcohol 14.0
PEG-8-Distearate 1.0
Hydrogenated Castor Oil 4.0
Talc 3.2
ZAG 24.0
Fragrance 0.8
The cyclomethicones were employed at different weight
levels of pentameric (D5) and hexameric (D6) as follows.
A All D5
B 5.3:1 of D5:D6
C 1.75:1 of D4:D5
D 1.5:1 of D5:D6 (representative of DC
E 1:1 of D5:D6
F All D6
The test procedure for identifying whitening involved
application of a layer of about 170 milligrams to black
polyester fabric. Photos were taken at various times
after application, including initial, 30, 60, 90, 120,
150, 180, 210, 240 and 270 minutes. Mean whiteness levels
were calculated and are presented in Table VIII.
CA 02315799 2000-06-16
WO 99/33440 PCT/EP98/08148
14
TABIrE VII
wxITENESS
vALVEs
TIES A B C D E F
0 83.833 83.567 86.933 82.922 82.719 74.482
30 89.502 88.275 91.078 85.941 83.481 73.773
60 104.1 104.08 92.557 83.932 82.687 73.28
90 235.89 123.45 100.20 86.526 85.932 73.059
120 159.54 145.57 125.74 96.415 95.275 73.294
150 160.49 150.28 133.58 104.41 102.16 75.097
180 160.37 153.85 144.73 113.52 113.42 74.781
210 160.03 153.88 148.35 120.75 118.87 75.853
240 159.89 154.45 153.91 130.35 128.24 77.80
270 161.04 156.70 158.83 135.97 134.13 80.158
Change
from 77.207 73.133 71.897 53.048 51.411 5.676
initial
value
Results of the study indicate that Sample F (all D6) was
substantially better than the other samples at delaying
the onset of any whitening. Sample E also had an effect,
albeit much smaller. Samples A-D displayed various
degrees of unacceptable whitening.
CA 02315799 2000-06-16
WO 99/33440 PCT/EP98/08148
EXAMPLE 13
This Example presents comparative performance results with
the selected cyclomethicones in an antiperspirant dry
5 cream formulation. Six dry cream antiperspirants were
formulated with various weight ratios of pentameric and
hexameric cyclomethicones. The basic compositions are
outlined in Table VIII below.
10 TABLE VIII
COMPONENT WEIGHT %
Cyclomethicone 54.95
Elastomer 3.26
Corn Starch 15.10
ZAG 2 6 . 0 0
Fragrance 0.70
The cyclomethicones were employed at different weight
levels of pentameric (D5) and hexameric (D6) as follows.
G All D5
H 0.2:1 of D5:D6
I 5.3:1 of D5:D6
J 1:1 of D5:D6
K 1.5:1 of D5:D6 (representative of DC
L 1.75:1 of D5:D6
The test procedure for identifying whitening involved
application of a layer of about 0.6 micron to black
polyester fabric. Photos were taken at various times
after application, including initial, 30, 60, 90, 120,
150, 180, 210, 240 and 270 minutes. Mean whiteness levels
were calculated and are presented in Table IX.
CA 02315799 2000-06-16
WO 99/33440 PCT/EP98/08148
16
TABLE IX
b~AN 1A18ITENE88
VALOES
TI>1Q: G H I J K L
0 67.676 76.340 71.159 71.624 71.402 65.206
30 67.097 76.656 70.260 68.823q 70.012 64.344
60 66.118 76.042 68.693 67.357 68.415 63.037
90 66.288 72.559 66.217 63.883 64.828 60.235
120 74.933 72.251 70.125 64.769 65.264 61.030
150 83.659 71.547 75.124 65.010 66.118 62.256
180 95.328 71.040 81.239 66.474 68.152 64.680
210 107.677 70.083 88.771 68.918 72.038 67.025
240 117.483 69.469 96.833 71.575 75.921 71.109
270 128.203 69.307 106.750 75.024 80.987 75.814
Change
from 60.527 - 7.033 35.591 3.400 9.585 10.608
initial
value
Sample G (all D5) whitened the quickest. Sample H
(highest level of D6) whitened the least. Sample J (with
equal amounts D5 and D6) was also relatively non-
whitening, the change from its initial value being second
smallest among the group of samples investigated.
The foregoing description and examples illustrate selected
embodiments of the present invention. In light thereof
variations and modifications will be suggested to one
skilled in the art, all of which are within the spirit and
purview of this invention.
